Disposition and tissue distribution of boron after infusion of borocaptate sodium in patients with malignant brain tumors
- 1 June 1998
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 41 (3) , 631-638
- https://doi.org/10.1016/s0360-3016(98)00069-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Interspecies pharmacokinetic scaling of BSH in mice, rats, rabbits, and humansBiopharmaceutics & Drug Disposition, 1995
- 11B nuclear magnetic resonance studies of the interaction of borocaptate sodium with serum albuminBiochemical Pharmacology, 1995
- Biodistribution of Boron Sulfhydryl for Boron Neutron Capture Therapy in Patients with Intracranial TumorsNeurosurgery, 1995
- Comparison of the Akaike Information Criterion, the Schwarz criterion and the F test as guides to model selectionJournal of Pharmacokinetics and Biopharmaceutics, 1994
- Clinical phase-I study of NA2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT)International Journal of Radiation Oncology*Biology*Physics, 1994
- Nephrotoxicity of borocaptate after short-term administration in rabbitsToxicology, 1993
- Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, l-boronophenylalanine and boric acid in murine tumorsRadiotherapy and Oncology, 1993
- Interaction between serum albumin and mercaptoundecahydrododecaborate ion (an agent for boron-neutron capture therapy of brain tumor). I. Introductory remarks and preliminary experiments.CHEMICAL & PHARMACEUTICAL BULLETIN, 1975
- Penetration of Brain and Brain Tumor. VII. Tumor-Binding Sulfhydryl Boron CompoundsJournal of Medicinal Chemistry, 1967
- Determination of Hydrolytically-Stable Boron Hydrides in Biological Materials.Analytical Chemistry, 1964